Maudsley Deprescribing Guidelines
Dubbelkollade priser
Jämför 1 butik
- Adlibris, 913 kr, frakt enligt butiken. Till butik (öppnas i ny flik)
Slut i lagerFrakt: se butikenDubbelkollad 27 okt. 09:10
913 kr
Priser från butikernas flöden kan ha ändrats: det är priset hos butiken som gäller, så kontrollera det innan du handlar.
Prishistorik
Köp nu eller vänta?
- Lägst
- 902 kr
- Snitt
- 912 kr
- Högst
- 913 kr
| 2026-09-15 | 902 kr · Lägst hos Adlibris |
|---|---|
| 2026-09-17 | 913 kr · Lägst hos Adlibris |
| 2026-10-06 | Ingen butik hade produkten i lager |
| 2026-10-08 | 913 kr · Lägst hos Adlibris |
| 2026-10-23 | Ingen butik hade produkten i lager |
Om produkten
Maudsley Deprescribing Guidelines
Läs merLäs mindre
The Maudsley® Deprescribing Guidelines Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more. Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so. The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in